About Kleef and Helixor
Mistletoe Products from Helixor
Helixor® Medical Products are exclusively distributed in Nigeria by KLEEF & HELIXOR Pharmaceutical Nigeria Ltd. Helixor® mistletoe therapy products are injectable medications which are approved to be used in integrative oncology. Two types of Helixor® can be obtained, gained from mistletoes which have grown on different host trees:
Helixor® A (Viscum album abietis)
Helixor® M (Viscum album mali)
How to use Helixor®
Please find the product characteristics.
Learn more about the products and pharmacological effects of Helixor® A, Helixor® M.
Please find the instructions for subcutaneous injection.
Please find information about the mistletoe plant.
How to get Helixor®
Helixor Heilmittel GmbH
The products are produced by Helixor Heilmittel GmbH in Germany. The company is active in more than 20 countries and has more than 40 years of experience in natural products in integrative oncology. The company controls the complete production process from the harvest of pharmaceutical plants over extraction, purification, and ampoule filling to distribution and after sales services. All Helixor® mistletoe products are manufactured in line with the European Union’s “Good Manufacturing Practice” (GMP) guidelines and are subject to strict quality control. Further information: www.helixor.com
– a pharmaceutical company for integrative medicine
Helixor Heilmittel GmbH is an international company in the field of integrative oncology. Our focus is on manufacturing and distributing remedies from mistletoe (Viscum album) and Christmas rose (Helleborus niger).
Integrative cancer therapy
Today, a great number of people are seeking out natural remedies and therapies in addition to conventional treatments – not as alternatives, but as complements. Patients want to actively participate in therapy and to improve their quality of life. Many want to use natural remedies to activate self-healing and thus stand up to the cancer.
Mistletoe therapy plays a major role in this. The white-berry mistletoe (Viscum album) is the most commonly used – and most thoroughly tested – medicinal product in complementary oncology. To date, mistletoe’s effects on various malignant diseases have been researched in over 100 clinical trials – and 26 of these trials used Helixor products.
Medicinal products made from two species of helleborus (Helleborus niger = Christmas rose, Helleborus foetidus = bear´s foot) are also successfully used for complementary cancer treatment.
Both therapeutic approaches are based on complementary medicine as an addition to conventional medicine.
Integrative cancer therapy combines complementary and conventional medicine for the patient’s benefit.
Helixor Complementary Cancer Treatment Drugs available from us are:
- Helixor A with 5 different dosages.
1mg, 5mg, 20mg, 50mg, 100mg
- Helixor M with 5 different dosages.
1mg, 5mg, 20mg, 50mg, 100mg
About YURiA Pharma
Founded in 1998, «YURiA-PHARM» focused its efforts on production of infusions and as of today is a leading infusion manufacturer not only in Ukraine, but also in CIS. YURiA-PHARM supplies medical facilities with more than 100 items of blood- and plasma substitute solutions, original infusion drugs, antibiotics, fungicidal drugs, syrups, antiseptics, parenteral nourishment preparations, anti-tuberculosis drugs, syringes, I.V. sets. The company’s product line sums up to more than 40 infusions, completely covering the needs of medical facilities in infusion therapy. Annual turnover of the company exceeds 60 million bottles. The company delivers products to Russia, Moldova, Kazakhstan, Uzbekistan, Azerbaijan, Tajikistan, Kirgizia, Turkmenistan, Georgia, Uganda, Kenya and Namibia. More than 100 items are now being registered for usage in different countries and the number is continuously growing. In 2008 «YURiA-PHARM» Corporation has received a Certificate of compliance to international quality management standards ISO 9001 (9001:2009). In 2011 «YURiA-PHARM » Corporation has completed GMP certification. «YURiA-PHARM» total headcount is constantly growing and at the moment exceeds 800, 2/3 of them being involved in production and R&D. The company is represented in Nigeria by Kleef & Helixor Pharm Nigeria Limited.
The company is the representative of YURiA Pharma a foremost East European Pharmaceutical company based in Kiev, Ukraine. www.uf.ua
Products available in Nigeria from YURiA Pharma are as follows:
Lacerta (Skin regeneration)
Dial (Osteoarthritis injection)
Revul Homeostatic (Blood Stopper)
Bitub Isoniazid Syrup (for TB Treatment & Prevention)
Inbutol (TB treatment Drug)
Starloxe (Leflocin Antibitiotic injection)
Ulaizer Home Nebulizer (Respiratory device)
Ulaizer Pro Nebulizer (Respiratory device)
Nebulizer Kits & Accessories (Respiratory device)